Scancell doses first patient in melanoma-focused trials
26th Mar 2024 14:00
(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic. Read More
| Price | 9.60p on 23-04-2024 at 16:30:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 9.80p |
| Sell | 9.40p |
| Buy / Sell SCLP Shares | |
| Last Trade: | Sell 98,990.00 at 9.425p |
| Day's Volume: | 319,243 |
| Last Close: | 9.60p |
| Open: | 9.60p |
| ISIN: | GB00B63D3314 |
| Day's Range | 9.60p - 9.60p |
| 52wk Range: | 7.65p - 17.375p |
| Market Capitalisation: | £89m |
| VWAP: | 9.49514p |
| Shares in Issue: | 929m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Recent Trades History Scancell Holdings (SCLP) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 98,990 | 9.425p | Ordinary |
15:25:25 - 23-Apr-24 |
| Sell* | 554 | 9.426p | Ordinary |
13:51:28 - 23-Apr-24 |
| Sell* | 10 | 9.542p | Ordinary |
12:14:59 - 23-Apr-24 |
| Sell* | 9,971 | 9.542p | Ordinary |
11:47:26 - 23-Apr-24 |
| Sell* | 2,569 | 9.425p | Ordinary |
11:39:34 - 23-Apr-24 |
| Sell* | 100 | 9.425p | Ordinary |
11:13:44 - 23-Apr-24 |
| Sell* | 95,566 | 9.53p | Ordinary |
10:40:10 - 23-Apr-24 |
| Sell* | 2,000 | 9.42p | Ordinary |
09:26:47 - 23-Apr-24 |
| Sell* | 104,900 | 9.53p | Ordinary |
08:57:24 - 23-Apr-24 |
| Sell* | 1,808 | 9.53p | Ordinary |
08:48:33 - 23-Apr-24 |